Home / Resource Library / New Community-Setting Data Affirm Ibrutinib’s Efficacy in R/R MCLNew Community-Setting Data Affirm Ibrutinib’s Efficacy in R/R MCL Study examined the real world efficacy and outcomes of ibrutinib for the treatment of relapsed mantle cell lymphoma.